New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
Go back to New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma| (NASDAQ: EVAX) | Delayed: 3.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.42 | 52 Week High | $ | |||
| Open | $3.42 | 52 Week Low | $ | |||
| Day High | $3.42 | P/E | N/A | |||
| Day Low | $3.42 | EPS | $ | |||
| Volume | 1 | |||||
